THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
https://doi.org/10.20996/1819-6446-2014-10-5-488-494
Abstract
Aim. To study the role of immune inflammatory reactions and endothelial dysfunction in myocardial remodeling and progression of ischemic heart disease (IHD).
Material and methods. 413 patients with IHD including 251 patients with stable and 162 patients with unstable angina were enrolled into the study. 55 healthy subjects were included into control group. Myocardial remodeling was studied by echocardiography. Immune inflammatory reactions were studied by detection of primary and secondary products of lipid peroxidation and antioxidative enzymes, pro- and antiinflammatory cytokines. Endothelial function was assessed by endothelium-dependent vasodilatation (EDVD) and levels of endothelin-1 (ET-1) and adhesion molecules.
Results. Correlation analysis showed relations of indicators of lipid peroxidation and antioxidative enzymes with proinflammatory cytokines – interleukin-1β, interleukin-6, tumor necrosis factor-alpha (TGF-α) (r=-0.39; -0.54; -0.42, respectively; р<0.05) and EDVD, ET-1 and E-selectin (r=-0.44; 0.52; 0.49, respectively; р<0.05). Interrelations of lipid peroxidation products and glutathione peroxidase with hemodynamic parameters were found out, as well as between TGF-αconcentration and indicators of myocardial remodeling. Strong correlations were revealed between parameters of endothelial and myocardial functions.
Conclusion. The role of immune inflammatory reactions and endothelial dysfunction in myocardial remodeling and IHD progression was established on the basis of the correlation analysis.
About the Authors
N. E. Zakirova
Bashkir State Medical University
Russian Federation
Lenina ul. 3, Ufa, 450000 Bashkortostan, Russia
Russian Federation
Lenina ul. 3, Ufa, 450000 Bashkortostan, Russia
A. N. Zakirova
Bashkir State Medical University
Russian Federation
Lenina ul. 3, Ufa, 450000 Bashkortostan, Russia
Russian Federation
Lenina ul. 3, Ufa, 450000 Bashkortostan, Russia
References
1. Boytsov SA, Samorodskaya IV. Dynamics of cardiovascular mortality among men and women in the Russian Federation. Kardiologiya 2014; 4: 4-9. Russian (Бойцов С.А., Самородская И.В. Динамика сер-дечно-сосудистой смертности среди мужчин и женщин в субъектах Российской Федерации. Кар-диология 2014; 4:4-9).
2. Belenkov YN. Ischemic heart disease as a major cause of heart failure. Serdechnaya nedostatochnost' 2004; 5 (2): 77-8. Russian (Беленков Ю.Н. Ишемическая болезнь сердца как основная причи-на сердечной недостаточности. Сердечная недостаточность 2004; 5(2):77-8).
3. Lankin VZ, Tihaze AK, Belenkov YN. Free-radical processes in diseases of the cardiovascular system. Kardiologiya 2000; 7: 48-61. Russian (Ланкин В.З., Тихазе А.К., Беленков Ю.Н. Свободнорадикаль-ные процессы при заболеваниях сердечно-сосудистой системы. Кардиология 2000; 7:48-61).
4. Chereshnev VA, Gusev E. Immunological and pathophysiological mechanisms of systemic inflammation. Meditsinskaya immunologiya 2012; 14 (1-2): 9-20. Russian (Черешнев В.А., Гусев Е.Ю. Им-мунологические и патофизиологические механизмы системного воспаления. Медицинская им-мунология 2012; 14(1-2): 9-20).
5. Yogiatzi G., Tousoulis D., Stefandis C. The role of oxidative stress in atherosclerosis. Hellenic J Сardiol 2009; 50: 402-9.
6. Valko M., Leibfritz D., Moncol J. еt al. Free radicals and antioxidants in normal physiological function and human disease. Int J Biochem Сеll Biol 2007; 39:44-84.
7. Landmesser U., Spickermann S., Dikalov S. et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xantine-oxidase and extacellur superoxide dismutase. Circulation 2002; 106: 3073-8.
8. Davignon I., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109 (23 Suppl 1): III 27-32.
9. Lubos E., Handy D.E., Loscalzo D. Role of oxidative stress and nitric oxide in atherotrombosis. Front Biosci 2005; 13:5323-5344.
10. Lutay MI, Golikova IP, Slobodskoi VA. The role of endothelial dysfunction, inflammation and dyslipidemia in atherogenesis. Ukrainskiy Kardiologicheskiy Zhurnal 2007; 5: 37-47. Russian (Лутай М.И., Голикова И.П., Слободской В.А. Роль дисфункции эндотелия, воспаления и дислипидемии в атерогенезе. Украинский Кардиологический Журнал 2007; 5:37-47).
11. Libby P., Okamoto Y., Roscha V.Z., Folco E. Inflamation in atherosclerosis: transition from theory to practice. Circ J. 2010; 74:213-20.
12. Oliveira G.H. Novel Serologic markers of Cardiovascular risk. Curr Atheroecler Rep 2005; 7: 148-54.
13. Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerons. Cell Tissue Res 2009; 335(1):191-203.
14. Wanhoutte R.M. Endothelial dysfunction: the first step toward coronary arterioslerosis. Circ J 2009; 73(4): 595-601.
15. Ivanov SG, Sitnikova MY, Shlyakhto EV. The role of oxidative stress in the development and progression of chronic heart failure: the relevance and the possibility of correction. Kardiologiya SNG 2006; 4: 267-70. Russian (Иванов С.Г., Ситникова М.Ю., Шляхто Е.В. Роль оксидативного стресса в раз-витии и прогрессировании хронической сердечной недостаточности: актуальность и возмож-ность коррекции. Кардиология СНГ 2006; 4:267-70).
16. Belenkov YN, Tatenkulova SN, Mareev VY et al. Relationship of proinflammatory factors with the severity of heart failure in coronary artery disease. Serdechnaya Nedostatochnost' 2009; 3: 286-90. Russaian (Беленков Ю.Н., Татенкулова С.Н., Мареев В.Ю. и др. Взаимосвязь уровня провоспали-тельных факторов с выраженностью сердечной недостаточности при ишемической болезни серд-ца. Сердечная Недостаточность 2009; 3:286-90).
17. Gonzalez Y.A., Selwyn A.P. Endothelial function, inflammation and prognosis in cardiovascular disease. Am J Med 2003; 115:96-106.
18. Тaub P.R., Gabbat-Saldate P., Maisel A. Biomarkers of heart failure. Congest Heart Fail 2010; 16(1): 19-24.
19. Biasillo G., Leo M.,Della Bona R., Biasacci M. Inflammatory biomarkers and coronary heart dissase: from bench to bedside and back. Intern Emerg Med 2010; 5:225-33.
20. Braunvald E., Jones R.H., Mark D.B. et al. Diagnosing Med managing unstable angina. Circulation 1994; 90:613-22.
21. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 2003; 108(9): 146-62.
22. Zakirova NE. Clinico-functional and biochemical determinants of acute coronary syndrome. Kardiovaskulyarnaya Terapiya i Profilaktika 2004; 2: 53-8. Russian (Закирова Н.Э. Клинико-функциональные и биохимические детерминанты острого коронарного синдрома. Кардиоваскулярная Терапия и Профилактика 2004; 2:53-8).
23. Zakirova AN, Zakirova NE. The role of lipid peroxidation, antioxidant protection and flow disturbances in the development of coronary heart disease. Rossiyskiy Kardiologicheskiy Zhurnal 2006; 2: 24-7. Russian (Закирова А.Н., Закирова Н.Э. Роль перекисного окисления липидов, антиоксидантной защиты и реологических нарушений в развитии ишемической болезни сердца. Российский Кар-диологический Журнал 2006; 2:24-7).
24. Celermajer D.S., Sorensen K.E., Gooch Y.M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-5.
25. Zakirova NE, Hafizov NH, Karamova IM et al. Immunological reaction in coronary heart disease. Ration Pharmacother Cardiol 2007; (2): 16-9. Russian (Закирова Н.Э., Хафизов Н.Х., Карамова И.М. и др. Иммуновоспалительные реакции при ишемической болезни сердца. Рациональная Фар-макотерапия в Кардиологии 2007; (2):16-9).
26. Oganov RG, Zakirova NE, Zakirova AN et al. Immunological reaction in acute coronary syndrome. Ration Pharmacother Cardiol 2007; (5): 15-9. Russian (Оганов Р.Г., Закирова Н.Э., Закирова А.Н. и др. Иммуновоспалительные реакции при остром коронарном синдроме. Рациональная Фар-макотерапия в Кардиологии 2007; (5):15-9).
27. Kuznetsov VA, Soldatova AM, Enina GN. Biomarkers of inflammation in patients with chronic heart failure with implantable devices for heart resinhronizizuyuschey therapy. Kardiologiya 2012; 8: 38-43. Russian (Кузнецов В.А., Солдатова А.М., Енина Г.Н. Биомаркеры воспаления у больных хро-нической сердечной недостаточностью с имплантированными устройствами для сердечной ре-синхронизизующей терапии. Кардиология 2012; 8: 38-43).
28. Bradman W., Bolkurt B., Gunasinghe H. et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res 2002; 53:822-30.
29. Belardinelli R., Tiano J., Iittarri G P. Oxidative Stress, endothelial function and coenzyme Q10. Biofactors 2008; 32:129-30.
30. Misra M.K., Sarwat M., Bhakun P. et al. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009; 15:209-19.
31. Zakirova NE, Oganov RG, Zakirova AN et al. Endothelial dysfunction in coronary artery disease. Ration Pharmacother Cardiol 2008; (4): 23-7. Russian (Закирова Н.Э., Оганов Р.Г., Закирова А.Н. и др. Дисфункция эндотелия при ишемической болезни сердца. Рациональная Фармакотерапия в Кардиологии 2008; (4):23-7).
32. Zakirova AN, Oganov RG, Zakirova NE et al. Myocardial remodeling in ischemic heart disease. Ration Pharmacother Cardiol 2009; (1): 42-5. Russian (Закирова А.Н., Оганов Р.Г., Закирова Н.Э. и др. Ремоделирование миокарда при ишемической болезни сердца. Рациональная Фармакотера-пия в Кардиологии 2009; (1):42-5).
33. Kapelko VI. Evolution of the concept and the metabolic basis of ischemic myocardial dysfunction. Kardiologiya 2005; 9: 55-61. Russian (Капелько В.И. Эволюция концепции и метаболическая ос-нова ишемической дисфункции миокарда. Кардиология 2005; 9:55-61).
34. Glordano F.J. Oxygen, oxidative stress, hypoxia and heart failure. S Clin Invest 2005; 115: 500-8.
35. Kloner R.A., Lennings R.B. Consequences of brief ischemia: stunning, preconditioning and thear clinical implications. Circulation 2001; 104:1:2981-9.
36. Libby P., Pidker M.P., Hansson G.K. Inflammation in atherosclerosis. J Am Cell Cardiol 2009; 54: 21-9.
37. Paleev FN, Suchkov SV, Kotova AA, et al. Tumor necrosis factor-αand interferon-αin patients with myocarditis. Kardiologiya 2004; 11: 34-8. Russian (Палеев Ф.Н., Сучков С.В., Котова А.А. и др. Фактор некроза опухоли-αи интерферон-αу больных миокардитом. Кардиология 2004; 11: 34-8).
38. Mann D.L., Recent insights into role of tumor necrosis factor in failing heart. Heart Fail Rev 2001; 6: 71-80.
39. Gong K., Song G., Spiers J., et al Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches. Int J Clin Pract 2007; 61: 611-21.
40. Satoh M., Nakamura M., Tamura G. et al. Inducible nitric oxide synthase and tumor necrosis factora in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997; 29:716-24.
41. Tsyplenkova VG. Critical notes on the paradigm of "hibernating and stunned myocardium." Kardiologiya 2005; 9: 43-6. Russian (Цыпленкова В.Г. Критические заметки по поводу парадигмы «гибер-нирующий и оглушенный миокард». Кардиология 2005; 9: 43-6).
42. Sawer D.B., Localzo J. Myocardial hibernation. Rectorative or preterminal sleep? Circulation 2002; 105:1517-9.
43. Teerlink J.R. Endothelins: pathophysiology and treatment implication in chronic hear failure. Current Heart Failure Reports 2005; 2: 191-7. Поступила: 10.10.2014
Review
For citations:
Zakirova N.E., Zakirova A.N. THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE. Rational Pharmacotherapy in Cardiology. 2014;10(5):488-494. (In Russ.) https://doi.org/10.20996/1819-6446-2014-10-5-488-494
Views: 642
Email this article 